INDBInternet News Database 2.5 Updated 1 min ago · 293 sources Show or hide images Light or dark

Results for “Bren Professor”

Climate
1 source

Who is covering this

Hindustan TimesCenter
Truth score 401
Centre 100%100%
Hindustan TimesCenter

AI Pioneer On How Her 'Neural Operators' Are Changing Weather Prediction, Nuclear Science| HTLS 2026

Can artificial intelligence make scientific simulations a million times faster — and unlock discoveries that were once beyond the reach of even the world's most powerful supercomputers? At the 24th edition of the Hindustan Times...

Lean: Center VideoFactuality: HighCountry: IndiaFunding: CorporateOwner: HT Media
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
HT Media100%
Avg reliability72
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 40 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 8 Amplification: 0

How we score

Like
Science
1 source

Who is covering this

Hindustan TimesCenter
Truth score 401
Centre 100%100%
Hindustan TimesCenter

AI Pioneer On Whether It's Time To Stop Celebrating New LLMs Until Hallucination Is Fixed| HTLS 2026

Can AI become an independent scientific collaborator, or is the promise of autonomous AI scientists overhyped? At the 24th edition of the Hindustan Times Leadership Summit, Professor Anima Anandkumar, Bren Professor at Caltech, explains...

Lean: Center VideoFactuality: HighCountry: IndiaFunding: CorporateOwner: HT Media
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
HT Media100%
Avg reliability72
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 40 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 8 Amplification: 0

How we score

Like
Science
1 source
Truth score 41
Right 100%100%
South China Morning PostLeans right

Chinese drug iza-bren doubles lung cancer survival window in phase 3 trial

An anticancer drug developed by Sichuan Biokin Pharmaceutical took centre stage in a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) Congress in Madrid last week. Researchers said the drug, iza-bren,...

Lean: Leans right Fact-focusedFactuality: HighCountry: Hong KongFunding: CorporateOwner: Alibaba Group
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
Hong Kong100%
Media ownership
Alibaba Group100%
Avg reliability75
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 41 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 75 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Like